Search images on Google      Product Monograph

Active Ingredients:

• tetrakis [cu(mibi)4]bf4, 1 MG/VIAL

DIN: 02328003

Dosage Form(s): POWDER FOR SOLUTION

Route(s) of Administration: INTRAVENOUS

Schedule: Schedule C

Company: LANTHEUS MI CANADA INC

ATC:

• V09 - DIAGNOSTIC RADIOPHARMACEUTICALS (ATC, WHO, Wiki)
• V09G - CARDIOVASCULAR SYSTEM (ATC, WHO)
• V09GX - Other cardiovascular system diagnostic radiopharmaceuticals (ATC, WHO)
• V09GX - OTHER CARDIOVASCULAR SYSTEM DIAGNOSTIC RADIOPHARM. (WHO)

Packaging:

• Package size unit: No information
• Package type: No information
• Package size: No information
• Product information: 2/5/20/30 X 5ML VIALS

 

External Links for Cardiolite:

Search on Google

• Cardiolite side effects
• Cardiolite dosage
• tetrakis [c side effects
• tetrakis [c dosage